In one paragraphArticle in Future microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Izabella Ventura SouzaPostgraduate Program of Biosciences and Physiopathology, Department of Clinical Analysis and Biomedicine, State University of Maringa, Maringa, Parana, Brazil.ORCID 0000-0003-1083-6242 Maria Luiza Fróes da Motta DacomePostgraduate Program of Biosciences and Physiopathology, Department of Clinical Analysis and Biomedicine, State University of Maringa, Maringa, Parana, Brazil.ORCID 0000-0001-5884-9902 Andrew Matheus Frederico RozadaDepartment of Chemistry, State University Maringa, Maringa, Parana, Brazil.ORCID 0000-0001-8151-7949 Jonathan Sanches RosaPostgraduate Program of Biosciences and Physiopathology, Department of Clinical Analysis and Biomedicine, State University of Maringa, Maringa, Parana, Brazil.
Eloisa Gibin SampironPostgraduate Program in Health Sciences, State University of Maringa, Maringa, Parana, Brazil.ORCID 0000-0002-4337-0007 Deisiany Gomes FerreiraPostgraduate Program in Health Sciences, State University of Maringa, Maringa, Parana, Brazil.ORCID 0000-0001-6601-6046 Melyssa Fernanda Norman NegriPostgraduate Program in Health Sciences, State University of Maringa, Maringa, Parana, Brazil.ORCID 0000-0003-2071-8872 Regiane Bertin de Lima ScodroPostgraduate Program in Health Sciences, State University of Maringa, Maringa, Parana, Brazil.ORCID 0000-0002-9129-2445 Rosilene Fressatti CardosoPostgraduate Program of Biosciences and Physiopathology, Department of Clinical Analysis and Biomedicine, State University of Maringa, Maringa, Parana, Brazil.ORCID 0000-0001-6228-4780 Katiany Rizzieri Caleffi-FerracioliPostgraduate Program of Biosciences and Physiopathology, Department of Clinical Analysis and Biomedicine, State University of Maringa, Maringa, Parana, Brazil.ORCID 0000-0003-0345-1600 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Antitubercular AgentsHydrazonesMicrobial Sensitivity TestsMycobacterium tuberculosisOxadiazolesAnimalsHumansMiceTuberculosisAntitubercular AgentsHydrazonesOxadiazolesanti-tuberculosis activityMycobacterium tuberculosisnew drugsoxadiazolestuberculosis resistance
Identifiers
PMID39440547
PMCPMC11974343
What OpenQuestion holds
Textmetadata
Read underepoch 390